269 related articles for article (PubMed ID: 33649836)
1. Exosomal connexin 43 regulates the resistance of glioma cells to temozolomide.
Yang ZJ; Zhang LL; Bi QC; Gan LJ; Wei MJ; Hong T; Tan RJ; Lan XM; Liu LH; Han XJ; Jiang LP
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649836
[TBL] [Abstract][Full Text] [Related]
2. Exosomes Derived from Glioma Cells under Hypoxia Promote Angiogenesis through Up-regulated Exosomal Connexin 43.
Yang ZJ; Bi QC; Gan LJ; Zhang LL; Wei MJ; Hong T; Liu R; Qiu CL; Han XJ; Jiang LP
Int J Med Sci; 2022; 19(7):1205-1215. PubMed ID: 35919821
[TBL] [Abstract][Full Text] [Related]
3. Heparanase confers temozolomide resistance by regulation of exosome secretion and circular RNA composition in glioma.
Si J; Li W; Li X; Cao L; Chen Z; Jiang Z
Cancer Sci; 2021 Sep; 112(9):3491-3506. PubMed ID: 34036683
[TBL] [Abstract][Full Text] [Related]
4. Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression through multiple pathways and enhances temozolomide resistance in glioma.
Ding C; Yi X; Chen X; Wu Z; You H; Chen X; Zhang G; Sun Y; Bu X; Wu X; Lin Z; Gu J; Lin Y; Kang D
J Exp Clin Cancer Res; 2021 May; 40(1):164. PubMed ID: 33975615
[TBL] [Abstract][Full Text] [Related]
5. Exosomal circ-HIPK3 Facilitates Tumor Progression and Temozolomide Resistance by Regulating miR-421/
Han C; Wang S; Wang H; Zhang J
Cancer Biother Radiopharm; 2021 Sep; 36(7):537-548. PubMed ID: 32644821
[No Abstract] [Full Text] [Related]
6. PAMs inhibits monoamine oxidase a activity and reduces glioma tumor growth, a potential adjuvant treatment for glioma.
Li PC; Chen SY; Xiangfei D; Mao C; Wu CH; Shih JC
BMC Complement Med Ther; 2020 Aug; 20(1):252. PubMed ID: 32799864
[TBL] [Abstract][Full Text] [Related]
7. AS602801 sensitizes glioma cells to temozolomide and vincristine by blocking gap junction communication between glioma cells and astrocytes.
Zhang S; Gong Y; Wang H; Li Z; Huang Y; Fu X; Xiang P; Fan T
J Cell Mol Med; 2021 Apr; 25(8):4062-4072. PubMed ID: 33609076
[TBL] [Abstract][Full Text] [Related]
8. Novel approach to temozolomide resistance in malignant glioma: connexin43-directed therapeutics.
Grek CL; Sheng Z; Naus CC; Sin WC; Gourdie RG; Ghatnekar GG
Curr Opin Pharmacol; 2018 Aug; 41():79-88. PubMed ID: 29803991
[TBL] [Abstract][Full Text] [Related]
9. Exosomal circWDR62 promotes temozolomide resistance and malignant progression through regulation of the miR-370-3p/MGMT axis in glioma.
Geng X; Zhang Y; Lin X; Zeng Z; Hu J; Hao L; Xu J; Wang X; Wang H; Li Q
Cell Death Dis; 2022 Jul; 13(7):596. PubMed ID: 35817771
[TBL] [Abstract][Full Text] [Related]
10. Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma.
Zeng A; Wei Z; Yan W; Yin J; Huang X; Zhou X; Li R; Shen F; Wu W; Wang X; You Y
Cancer Lett; 2018 Nov; 436():10-21. PubMed ID: 30102952
[TBL] [Abstract][Full Text] [Related]
11. Connexin43 confers Temozolomide resistance in human glioma cells by modulating the mitochondrial apoptosis pathway.
Gielen PR; Aftab Q; Ma N; Chen VC; Hong X; Lozinsky S; Naus CC; Sin WC
Neuropharmacology; 2013 Dec; 75():539-48. PubMed ID: 23688923
[TBL] [Abstract][Full Text] [Related]
12. Effects of Connexin43 Overexpression on U251 Cell Growth, Migration, and Apoptosis.
Lu J; Yu M; Lin Z; Lue S; Zhang H; Zhao H; Xu Y; Liu H
Med Sci Monit; 2017 Jun; 23():2917-2923. PubMed ID: 28615614
[TBL] [Abstract][Full Text] [Related]
13. Exosome-mediated transfer of circRNA CircNFIX enhances temozolomide resistance in glioma.
Ding C; Yi X; Wu X; Bu X; Wang D; Wu Z; Zhang G; Gu J; Kang D
Cancer Lett; 2020 Jun; 479():1-12. PubMed ID: 32194140
[TBL] [Abstract][Full Text] [Related]
14. Curcumin Promotes Connexin 43 Degradation and Temozolomide-Induced Apoptosis in Glioblastoma Cells.
Huang BR; Tsai CH; Chen CC; Way TD; Kao JY; Liu YS; Lin HY; Lai SW; Lu DY
Am J Chin Med; 2019; 47(3):657-674. PubMed ID: 30974966
[TBL] [Abstract][Full Text] [Related]
15. NCK1-AS1 Increases Drug Resistance of Glioma Cells to Temozolomide by Modulating miR-137/
Chen M; Cheng Y; Yuan Z; Wang F; Yang L; Zhao H
Cancer Biother Radiopharm; 2020 Mar; 35(2):101-108. PubMed ID: 31750728
[No Abstract] [Full Text] [Related]
16. αCT1 peptide sensitizes glioma cells to temozolomide in a glioblastoma organoid platform.
Che J; DePalma TJ; Sivakumar H; Mezache LS; Tallman MM; Venere M; Swindle-Reilly K; Veeraraghavan R; Skardal A
Biotechnol Bioeng; 2023 Apr; 120(4):1108-1119. PubMed ID: 36544242
[TBL] [Abstract][Full Text] [Related]
17. Exosomes released from U87 glioma cells treated with curcumin and/or temozolomide produce apoptosis in naive U87 cells.
Mousavi SM; Hosseindoost S; Mahdian SMA; Vousooghi N; Rajabi A; Jafari A; Ostadian A; Hamblin MR; Hadjighassem M; Mirzaei H
Pathol Res Pract; 2023 May; 245():154427. PubMed ID: 37028110
[TBL] [Abstract][Full Text] [Related]
18. Apcin inhibits the growth and invasion of glioblastoma cells and improves glioma sensitivity to temozolomide.
Ding Y; Zhang C; He L; Song X; Zheng C; Pan Y; Yu S
Bioengineered; 2021 Dec; 12(2):10791-10798. PubMed ID: 34753395
[TBL] [Abstract][Full Text] [Related]
19. Exosomal transfer of miR‑25‑3p promotes the proliferation and temozolomide resistance of glioblastoma cells by targeting FBXW7.
Wang J; Li T; Wang B
Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34278448
[TBL] [Abstract][Full Text] [Related]
20. Brachyury Is Associated with Glioma Differentiation and Response to Temozolomide.
Pinto F; Costa ÂM; Andrade RP; Reis RM
Neurotherapeutics; 2020 Oct; 17(4):2015-2027. PubMed ID: 32785847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
